In a randomized, double-blind, placebo-controlled study of people suffering from amnestic mild cognitive impairment or Alzheimer's Disease (AD), intranasal insulin preserved cognitive function compared to placebo [24]. Here, INS is linked to early-onset autosomal dominant Alzheimer disease.